|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
91,270,000 |
Market
Cap: |
148.77(M) |
Last
Volume: |
511,514 |
Avg
Vol: |
703,791 |
52
Week Range: |
$1.54 - $4.26 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Health Services |
Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Accuray is a radiation therapy company that develops, manufactures, sells and supports solutions that are designed to deliver radiation treatments. Co.'s technologies, the CyberKnife® and TomoTherapy® platforms, including the Radixact® System, its TomoTherapy platform, are designed to deliver various treatments, including stereotactic radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy, and adaptive radiation therapy. Co. also provides services, which include post-contract customer support (warranty period services and post warranty services), installation services, training, and other services.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
11,991 |
185,488 |
283,237 |
445,755 |
Total Sell Value |
$31,057 |
$464,222 |
$769,360 |
$1,119,320 |
Total People Sold |
1 |
7 |
7 |
8 |
Total Sell Transactions |
1 |
9 |
18 |
34 |
End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Weiss Robert S |
Director |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,762 |
222,560 |
|
- |
|
Pettingill Richard |
Director |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,762 |
82,363 |
|
- |
|
Lavigne Louis J Jr |
Director |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,762 |
155,441 |
|
- |
|
Goldstein Jack |
Director |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,762 |
104,660 |
|
- |
|
Davila Elizabeth H |
Director |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
23,762 |
115,560 |
|
- |
|
Waters Kevin |
SVP, Chief Financial Officer |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
38,200 |
322,925 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
21,600 |
199,623 |
|
- |
|
Londy Kelly |
EVP Chief Operating Officer |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
44,100 |
413,555 |
|
- |
|
Levine Joshua |
President & CEO |
|
2016-11-30 |
4 |
A |
$0.00 |
$0 |
D/D |
122,800 |
1,471,010 |
|
- |
|
Winger Dennis L |
Director |
|
2016-11-21 |
4 |
D |
$5.30 |
$36,135 |
D/D |
(6,818) |
118,798 |
|
- |
|
Weiss Robert S |
Director |
|
2016-11-21 |
4 |
D |
$5.30 |
$36,135 |
D/D |
(6,818) |
198,798 |
|
- |
|
Pettingill Richard |
Director |
|
2016-11-21 |
4 |
D |
$5.30 |
$36,135 |
D/D |
(6,818) |
58,601 |
|
- |
|
Lavigne Louis J Jr |
Director |
|
2016-11-21 |
4 |
D |
$5.30 |
$36,135 |
D/D |
(6,818) |
131,679 |
|
- |
|
Goldstein Jack |
Director |
|
2016-11-21 |
4 |
D |
$5.30 |
$36,135 |
D/D |
(6,818) |
80,898 |
|
- |
|
Davila Elizabeth H |
Director |
|
2016-11-21 |
4 |
D |
$5.30 |
$36,135 |
D/D |
(6,818) |
91,798 |
|
- |
|
Waters Kevin |
SVP, Chief Financial Officer |
|
2016-11-01 |
4 |
D |
$4.85 |
$6,756 |
D/D |
(1,393) |
284,725 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2016-11-01 |
4 |
D |
$4.85 |
$32,752 |
D/D |
(6,753) |
178,023 |
|
- |
|
Londy Kelly |
EVP Chief Operating Officer |
|
2016-11-01 |
4 |
D |
$4.87 |
$61,994 |
D/D |
(12,742) |
369,455 |
|
- |
|
Levine Joshua |
President & CEO |
|
2016-11-01 |
4 |
D |
$4.85 |
$361,145 |
D/D |
(74,506) |
1,348,210 |
|
- |
|
Waters Kevin |
SVP, Chief Financial Officer |
|
2016-10-03 |
4 |
D |
$6.24 |
$39,505 |
D/D |
(6,331) |
286,118 |
|
- |
|
Nouri Alaleh |
SVP, General Counsel & |
|
2016-08-29 |
4 |
D |
$5.39 |
$5,261 |
D/D |
(976) |
184,776 |
|
- |
|
Waters Kevin |
SVP, Chief Financial Officer |
|
2016-07-11 |
4 |
D |
$5.35 |
$25,998 |
D/D |
(4,864) |
292,449 |
|
- |
|
Londy Kelly |
EVP Chief Operating Officer |
|
2016-07-11 |
4 |
D |
$5.38 |
$28,290 |
D/D |
(5,259) |
382,197 |
|
- |
|
Levine Joshua |
President & CEO |
|
2016-07-11 |
4 |
D |
$5.36 |
$149,025 |
D/D |
(27,790) |
1,422,716 |
|
- |
|
Waters Kevin |
SVP, Chief Financial Officer |
|
2016-07-08 |
4 |
A |
$0.00 |
$0 |
D/D |
12,345 |
297,313 |
|
- |
|
835 Records found
|
|
Page 12 of 34 |
|
|